Saito H | Nagoya National Hospital
スポンサーリンク
概要
関連著者
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
小嶋 哲人
Department Of Transfusion Medicine Cardiology And Hematology Nagoya University Hospital
-
小嶋 哲人
名古屋大学医学部第一内科
-
小嶋 哲人
名古屋大学 保健
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
OJI Yusuke
Departments of Clinical Laboratory Science
-
TAWARA Masayuki
Nagasaki CML Study Group
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OHNO Ryuzo
Aichi Cancer Center
-
Sao Hiroshi
Department of Hematology, Meitetsu Hospital
-
Soma T
Department Of Medicine National Hospital Organization Osaka Minami Medical Center
-
Soma Toshihiro
大阪大学 医学系研究科
-
Soma Toshihiro
Medicine Iii Osaka University Medical School
-
TSUBOI Akihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OKA Yoshihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science University Of Tokyo
-
Kami Masahiro
Jr東京総合病院 血液内科
-
Iida Hiroatsu
Department of Hematology, Meitetsu Hospital
-
SAITO Hidehiko
Nagoya Central Hospital
-
KOJIMA Tetsuhito
Department of Medical Technology, Nagoya University School of Health Sciences
-
KAWASE Ichiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
NISHIDA Sumiyuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
ETO Tetsuya
Department of Hematology, Hamanomachi Hospital
-
Ogata Kentaro
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Hara Shuuji
Faculty of Pharmaceutical Sciences, Fukuoka University
-
谷脇 雅文
高知工科大学工学部
-
MATSUSHITA Tadashi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
KOHNO Akio
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
HOSEN Naoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
TESHIMA Takanori
Center for Cellular and Molecular Medicine, Kyushu University Hospital
-
SAKAMAKI Hisashi
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
Takamatsu Yasushi
First Department of Internal Medicine, Fukuoka University
-
Tamura Kazuo
First Department of Internal Medicine, Fukuoka University
-
Kunitomi Akane
Department of Hematology, Meitetsu Hospital
-
Kamiya Yoshikazu
Department of Hematology, Meitetsu Hospital
-
永井 正
自治医科大学内科学講座血液学部門
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学(整形外科)
-
NAKAYAMA Takayuki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Tobinai Kensei
東海大学 医学部
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Miyamoto Toshihiro
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
TAKAGI Akira
Department of Medical Technology, Nagoya University School of Health Sciences
-
SAWA Masashi
Department of Hematology, Anjo Kosei Hospital
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
永井 正
自治医科大学 内科学講座血液学部門
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
Seto M
Aichi Cancer Center Res. Inst. Nagoya
-
MATSUO Keitaro
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
HATA Tomoko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
JINNAI Itsuro
Nagasaki CML Study Group
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
KANAMORI Heiwa
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of
-
ATSUTA Yoshiko
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
MORI Takehiko
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
YOSHIDA Takashi
Hematology Department, Toyama Prefectural Hospital
-
Nagase Hideki
Department Of Pediatrics Nara Medical University
-
Honda Sumihisa
Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
MIYAWAKI Shuichi
Division of Hematology, Saiseikai Maebashi Hospital
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
KISHIMOTO Yuji
The First Department of Internal Medicine, Kansai Medical University
-
TAKAHASHI Masatomo
Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
NAGAFUJI Koji
Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine
-
KAMIMURA Tomohiko
Department of Hematology, Harasanshin General Hospital
-
TAMURA Kazuo
Division of Medical Oncology and Hematology, Department of Medicine, Fukuoka University Hospital
-
SUZUMIYA Junji
Department of Internal Medicine, Fukuoka University Chikushi Hospital
-
SAKAMAKI Hisashi
Division of Hematology, Tokyo Metropolitan Komagome Hospital
-
EMI Nobuhiko
Department of Hematology, Fujita Health University
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
MIYAZAKI Yasushi
The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Takase Daizi
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Matsumoto Taichi
Faculty of Pharmaceutical Sciences, Fukuoka University
-
Jimi Shiro
Central Laboratory of Pathology and Morphology, Fukuoka University
-
Hayashi Mayuko
Department of Hematology, Meitetsu Hospital
-
清水 隆之
慶應義塾大学医学部血液内科
-
TAKAMATSU Yasushi
Division of Oncology, Hematology, and Infectious Diseases, Department of Medicine, Fukuoka Universit
-
ANDO KOJI
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
TAKAMI Akiyoshi
Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
KAMI Masahiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
SONG Kyung
Department of Gastroenterology, Kobe Asahi Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
TSUCHIDA Masahiro
Department of Pediatrics, Ibaraki Children's Hospital
-
INOUE Masakazu
Department of Pediatrics, Yamada Red-Cross Hospital
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
FUJIWARA TOHRU
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
OHASHI Haruhiko
Clinical Research Center for Blood Disease, National Hospital Organization Nagoya Medical Center
-
CHOI Yong
Department of Advanced Materials Engineering, Sunmoon University
-
TSUKASAKI Kunihiro
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
MATSUO Yuzi
the Department of Laboratory Midicine
-
OKADA Hiromi
Department of Hemostasis and Thrombosis, Clinical Research Center, Nagoya Medical Center
-
TOYODA Yoshimi
Department of Medical Technology, Nagoya University School of Health Sciences
-
YAMAZAKI Tomio
Department of Hemostasis and Thrombosis, Clinical Research Center, Nagoya Medical Center
-
NISHIWAKI Satoshi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
TERAKURA Seitaro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
YASUDA Takahiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
IMAHASHI Nobuhiko
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
NIIMI Keiko
Department of Hematology, Meitetsu Hospital
-
MORISHITA Yoshihisa
Department of Hematology and Oncology JA Aichi Konan Kosei Hospital
-
YOKOZAWA Toshiya
Clinical Research Center, National Hospital Organization Nagoya Medical Center
-
OKA Yoshihiro
Medicine III, Osaka University Medical School
-
TATEKAWA Toyoshi
Medicine III, Osaka University Medical School
-
MATSUNASHI Tatsuro
Medicine III, Osaka University Medical School
-
YAMAGAMI Tamotsu
Medicine III, Osaka University Medical School
-
TSUBOI Akihiro
Medicine III, Osaka University Medical School
-
TAMAKI Hiroya
Medicine III, Osaka University Medical School
-
KIM Eui
Medicine III, Osaka University Medical School
-
OGAWA Hiroyasu
Medicine III, Osaka University Medical School
-
YAMAGAMI Tamotsu
Department of Medicine, National Hospital Organization Osaka Minami Medical Center
-
KAWAKAMI Manabu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
KIM Eui
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OGAWA Hiroyasu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
MASUDA Tomoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
TANIGUCHI Yuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
Yamamoto Koji
Department of Internal Medicine, Hattori Memorial Hospital
-
Ogawa Daisuke
Nagasaki Cml Study Group
-
Matsushita Tadashi
Department Of Pathophysiological Laboratory Sciences Nagoya University Graduate School Of Medicine
-
HAMAJIMA Nobuyuki
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Gradu
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
SAKAI Mari
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MATSUO Emi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIUCHI Yukiyoshi
Nagasaki CML Study Group
-
FUKUSHIMA Takuya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IMAIZUMI Yoshitaka
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TAGUCHI Jun
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
IWANAGA Masako
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUSHIMA Hideki
Nagasaki CML Study Group
-
INOUE Yoriko
Nagasaki CML Study Group
-
TAKASAKI Yumi
Nagasaki CML Study Group
-
TSUCHIYA Takeshi
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
KOMODA Minori
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
HORIO Kensuke
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
MORIWAKI Yuji
Nagasaki CML Study Group
-
TOMINAGA Shinya
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
ITONAGA Hidehiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
NAGAI Kazuhiro
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TSUTSUMI Chizuko
Nagasaki CML Study Group
-
SAWAYAMA Yasushi
Nagasaki CML Study Group
-
YAMASAKI Reishi
Nagasaki CML Study Group
-
KAWAGUCHI Yasuhisa
Nagasaki CML Study Group
-
IKEDA Shuichi
Nagasaki CML Study Group
-
YOSHIDA Shinichiro
Nagasaki CML Study Group
-
ONIMARU Yasuyuki
Nagasaki CML Study Group
-
ATOGAMI Sunao
Nagasaki CML Study Group
-
KOIDA Satoshi
Nagasaki CML Study Group
-
JOH Tatsuro
Nagasaki CML Study Group
-
YAMAMURA Masaomi
Nagasaki CML Study Group
-
MATSUO Yuji
Nagasaki CML Study Group
-
SODA Hisashi
Nagasaki CML Study Group
-
NONAKA Hiroaki
Nagasaki CML Study Group
-
NISHIDA Tetsuya
Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital
-
HIRAI Hisamaru
Department of Hematology and Oncology, Graduate School of Medicine
-
HARA Masamichi
Division of Hematology, Ehime Prefectural Central Hospital
-
NAGAFUJI Koji
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science
-
MORI Shin-ichiro
Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital
-
HIDAKA Michihiro
Department of Internal Medicine, Kumamoto Medical Center, National Hospital Organization
-
YOSHIBA Fumiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
ICHINOHE Tatsuo
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
-
KASAI Masanobu
Department of Hematology, Nagoya Daini Red Cross Hospital
-
TAKATSUKA Yoshifusa
Department of Hematology, Imamura Bun-in Hospital
-
KUBO Kohmei
Department of Hematology, Aomori Prefectural Central Hospital
-
HARADA Mine
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science
-
Okamura T
Division Of Hematology Department Of Medicine Kurume University School Of Medicine
-
TANIWAKI Masafumi
Department of Environmental Systems Engineering, Kochi University of Technology
-
Nagase Hideki
大鵬薬品工業
著作論文
- A SIMPLE AND SELECTIVE HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PARAQUAT AND DIQUAT IN HUMAN URINE
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Structural Organization and Promoter Activity of the Human Ryudocan Gene
- Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
- Molecular Cloning, Genomic Organization, Promoter Activity, and Tissue-Specific Expression of the Mouse Ryudocan Gene^1
- Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
- Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
- Analysis of 55 Transplantations from Unrelated Volunteer Donors Facilitated by Tokai Marrow Donor Bank
- Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
- Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
- Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor
- Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
- Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin
- Genetic Abnormalities of Bernard-Soulier Syndrome
- Retrospective study of inhibitor formation in Japanese hemophiliacs
- Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
- Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
- A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
- Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation